Nevermined

Nevermined provides AI payment infrastructure, enabling seamless transactions between AI agents. Their protocol facilitates AI-to-AI commerce, helping developers monetize and manage AI services.

Headquarters

Year Founded

Search Tags

AI monetization platform, AI payment protocol, AI-to-AI transactions, blockchain for AI commerce, decentralized AI marketplace

About Us

Nevermined is a pioneering AI payment infrastructure company that facilitates seamless transactions between AI agents. Their protocol, often described as the “PayPal for AI,” enables AI developers to monetize their applications through efficient payment management, usage tracking, and credit systems. Nevermined’s decentralized platform supports the growing AI economy by providing scalable and secure payment solutions for AI-to-AI interactions. The company’s innovative approach to AI commerce addresses the unique challenges of autonomous transactions, positioning Nevermined as a key player in shaping the future of AI-driven financial ecosystems.

Trending Companies

Latest Articles

Engineer intelligent, AI-driven supply chain operations. Discover what next-generation leaders must master to design resilient, data-driven, high-performing global networks.

The Future of Supply Chain Leadership: Why the Next Generation Will Engineer Intelligence, Not Just Manage It

Supply chain leadership is being redefined by AI, intelligent automation, and agentic decision-making, demanding leaders who can engineer end-to-end intelligence rather than simply manage workflows. This article explores how next-generation supply chain leaders will combine data, algorithms, and human judgment to build resilient, adaptive, and high-performing global operations.

Read More >
Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >